Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

CGTN: Film on Japan's infamous WWII germ warfare unit to debut on September 18

CGTN published an article on the Chinese historical drama "731," which revisits the horrific human experiments carried out by Japan's notorious germ warfare Unit 731 during World War II. The article also highlights newly disclosed evidence of the unit's crimes and shows the unwavering spirit of the Chinese people in the face of despair.

BEIJING, Sept. 15, 2025 (GLOBE NEWSWIRE) -- A Chinese historical drama titled "731," which revisits the horrific World War II-era human experiments conducted by Japan's notorious germ warfare unit 731, is set to premiere across the globe on September 18.

Directed by Zhao Linshan, the film tells the story of Wang Yongzhang, a local vendor, and others who were imprisoned and lured by false promises of freedom in exchange for cooperation with health checks and disease prevention research.

Instead, they became victims of brutal medical experiments carried out by the occupying Japanese forces, including frostbite testing, gas exposure, and vivisection.

Unit 731, a top-secret biological and chemical warfare research base, was established in Harbin, capital of northeast China's Heilongjiang Province. It served as the nerve center for Japanese biological warfare in China and Southeast Asia during WWII.

Recently declassified documents from the Public Relations Center of the Russian Federal Security Service reveal that Unit 731 conducted continuous human experiments and attacked hundreds of Chinese people with pathogen-carrying artillery shells to calculate the infection rate and assess the "quality" of the pathogens. 

The documents also show the unit's secret plan to conduct a biological attack on the Soviet Union.

"This is a history that must never be forgotten," said Jin Chengmin, a historical adviser for the film and head of the Exhibition Hall of Evidences of Crime Committed by Unit 731 of the Japanese Imperial Army.

"The film reveals the inhumane atrocities committed by the invading Japanese army through the eyes of ordinary civilians, while highlighting the unyielding resistance spirit of the Chinese people in the face of despair," Jin said. "It serves as a powerful reminder to safeguard peace."

This year marks the 80th anniversary of the victory of the Chinese People's War of Resistance Against Japanese Aggression and the World Anti-Fascist War.

Its premiere date also coincides with the September 18 Incident in 1931, which marked the beginning of Japan's 14-year invasion of China.

During the war, China suffered more than 35 million casualties, both military and civilian, while Japanese troops committed countless heinous crimes that have drawn universal condemnation.

https://news.cgtn.com/news/2025-09-15/Film-on-Japan-s-infamous-WWII-germ-warfare-unit-to-debut-on-Sept-18-1GGWThTIpZC/p.html


Contact: CGTN cgtn@cgtn.com

Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.